» Authors » Oguz Bilgi

Oguz Bilgi

Explore the profile of Oguz Bilgi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 218
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karagoz B, Ozgun A, Emirzeoglu L, Tuncel T, Celik S, Bilgi O, et al.
J Breast Health . 2017 Mar; 11(1):48-51. PMID: 28331691
Lapatinib is an effective drug in HER2-positive breast cancer. We present a case with successful treatment of lapatinib in brain metastasis of HER2+ breast cancer. Forty-eight years old woman was...
2.
Akyol Erikci A, Karagoz B, Bilgi O
Turk J Haematol . 2016 May; 33(2):153-5. PMID: 27211045
Objective: Immune thrombocytopenic purpura (ITP) is an immune-mediated bleeding disorder in which platelets are opsonized by autoantibodies and destroyed by an Fc receptor-mediated phagocytosis by the reticuloendothelial system within the...
3.
Karagoz B, Bilgi O, Ozgun A, Emirzeoglu L, Celik S, Ozet A
J Egypt Natl Canc Inst . 2015 Mar; 27(3):161-3. PMID: 25773731
The prognosis of metastatic melanoma is poor. Pre-targeted treatment era, the combination of interferon-α (IF-α) plus chemotherapy had been used and have generally short response duration. Herein, we present a...
4.
Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Demir S, Bilgi O, et al.
Oncol Lett . 2015 Jan; 9(2):937-939. PMID: 25621071
Cancer is associated with an increased risk of cerebrovascular incidents and treatment with chemotherapy enhances that risk further. Brocha's aphasia is a stroke-related syndrome, the presentation of which has been...
5.
Ozgun A, Tuncel T, Emirzeoglu L, Celik S, Bilgi O, Haholu A, et al.
Oncol Lett . 2014 Dec; 9(1):468-470. PMID: 25436010
Malignant melanoma can be successfully treated when it is identified in its early stages, but the disease is associated with a poor prognosis when it is detected in an advanced...
6.
Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O, Karagoz B
Asian Pac J Cancer Prev . 2014 Aug; 15(15):6421-3. PMID: 25124636
Background: Recent studies have revealed a prognostic impact of the MPV (mean platelet volume)/platelet count ratio in terms of survival in advanced non-small cell lung cancer. However, there has been...
7.
Karagoz B, Haholu A, Ozgun A, Bilgi O, Tuncel T, Emirzeoglu L, et al.
Oncol Res Treat . 2014 May; 37(5):245-8. PMID: 24853783
Background: HLA-G is a non-classical major histocompatibility complex class I molecule. HLA-G expression has been found in various types of solid and hematological malignancies. It is also expressed in normal...
8.
Tuncel T, Karagoz B, Haholu A, Ozgun A, Emirzeoglu L, Bilgi O, et al.
Asian Pac J Cancer Prev . 2014 Jan; 14(12):7681-4. PMID: 24460353
Background: Human leukocyte antigen (HLA)-G-positive gastric cancers are associated with poor survival, but links with tumor escape mechanisms remain to be determined. Materials And Methods: We used immunohistochemistry to investigate...
9.
Ozgun A, Karagoz B, Tuncel T, Emirzeoglu L, Celik S, Bilgi O
Asian Pac J Cancer Prev . 2014 Jan; 14(11):6889-92. PMID: 24377621
Background: Testicular germ cell tumors (TGCTs) are a relatively common malignancy in young men. The aim of this study was to investigate the clinicopathological features and survival of young Turkish...
10.
Ozgun A, Karagoz B, Bilgi O, Tuncel T, Baloglu H, Kandemir E
Onkologie . 2013 Mar; 36(3):115-8. PMID: 23485999
Objective: The recently discovered microRNAs (miRNAs) are non-protein-coding, endogenous small RNAs. The aim of this study was to investigate the relationship between microRNA-21 (miR-21) and the clinicopathological features of breast...